Vaxcyte, Inc.

PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001649094

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 9, 20265:46 PM ETSep 4 – Sep 9, 2026Wassil JimEVP, Chief Scientific Ofc, COOSSaleCommon Stock−2.72K$60.3547−$163.86K145.44K−1.8%SEC
Sep 2, 20267:58 PM ETSep 1, 2026Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−3.48K$61.0732−$212.35K155.04K−2.2%SEC
Aug 5, 20267:01 PM ETAug 5, 2026Dhaliwal Harpreet S.Chief Technical Ops OfficerSSaleCommon Stock−17K$55.004−$935.07K76.76K−18.1%SEC10b5-1
Aug 5, 20264:59 PM ETAug 3, 2026Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−2.25K$53.8644−$121.19K157.54K−1.4%SEC10b5-1
Aug 5, 20264:58 PM ETAug 3, 2026GUGGENHIME ANDREWPRESIDENT AND CFOSSaleCommon Stock−10K$53.8879−$538.88K105.18K−8.7%SEC10b5-1
Jul 28, 20264:10 PM ETJul 27, 2026PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−16.2K$55.6284−$901.07K453.25K−3.5%SEC10b5-1
Jul 28, 20264:10 PM ETJul 27, 2026PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−2K$55.6533−$111.31K133.22K−1.5%SEC10b5-1
Jul 6, 20267:31 PM ETJul 6, 2026GUGGENHIME ANDREWPRESIDENT AND CFOSSaleCommon Stock−10K$57.2837−$572.84K104.4K−8.7%SEC10b5-1
Jul 6, 20266:25 PM ETJul 1, 2026Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−2.25K$56.3272−$126.74K156.76K−1.4%SEC10b5-1
Jun 26, 2026Jun 26, 2026PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−22.24K$55.2178−$1.23M452.47K−4.7%SEC10b5-1
Jun 26, 2026Jun 26, 2026PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−2K$55.2347−$110.47K134.22K−1.5%SEC10b5-1
Jun 18, 2026Jun 18, 2026PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−22.46K$52.5001−$1.18M474.7K−4.5%SEC10b5-1
Jun 18, 2026Jun 18, 2026PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−2K$52.50−$105K135.22K−1.5%SEC10b5-1
Jun 18, 2026Jun 18, 2026GUGGENHIME ANDREWPRESIDENT AND CFOSSaleCommon Stock−10K$53.00−$530K104.4K−8.7%SEC10b5-1
Jun 3, 2026Jun 1, 2026Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−2.25K$49.515−$111.41K158.49K−1.4%SEC10b5-1
May 1, 2026May 1, 2026Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−2.25K$56.83−$127.87K160.74K−1.4%SEC10b5-1
Apr 8, 2026Apr 7, 2026Cowan ElviaSVP, Finance & CAOSSaleCommon Stock−3K$60.00−$180K28.98K−9.4%SEC10b5-1
Apr 3, 2026Apr 1, 2026Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−2.25K$58.4342−$131.48K162.99K−1.4%SEC10b5-1
Mar 18, 2026Mar 17, 2026Cowan ElviaSVP, Finance & CAOSSaleCommon Stock−1.89K$55.5762−$105.15K28.98K−6.1%SEC10b5-1
Mar 11, 2026Mar 11, 2026Cowan ElviaSVP, Finance & CAOSSaleCommon Stock−2.5K$58.59−$146.48K30.87K−7.5%SEC10b5-1
Mar 11, 2026Mar 10, 2026Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−7.4K$58.8843−$435.45K166.82K−4.2%SEC10b5-1
Jan 2, 2026Dec 31, 2025Dhaliwal Harpreet S.Chief Technical Ops OfficerSSaleCommon Stock−9.74K$46.69−$454.9K23.93K−28.9%SEC
Dec 29, 2025Dec 23, 2025Cowan ElviaSVP, FINANCESSaleCommon Stock−11.62K$47.9231−$557.01K14.53K−44.4%SEC
Mar 7, 2025Mar 5, 2025Eydelman MikhailSVP, GEN COUNSEL & CORP SECSSaleCommon Stock−5K$70.7427−$353.71K41.62K−10.7%SEC10b5-1
Mar 3, 2025Mar 3, 2025Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−8K$73.2707−$586.17K154.93K−4.9%SEC10b5-1
Feb 19, 2025Feb 18, 2025GUGGENHIME ANDREWPRESIDENT AND CFOSSaleCommon Stock−8K$83.8536−$670.83K109.49K−6.8%SEC10b5-1
Feb 7, 2025Feb 5, 2025Eydelman MikhailSVP, GEN COUNSEL & CORP SECSSaleCommon Stock−5K$90.0741−$450.37K28.22K−15.1%SEC10b5-1
Feb 4, 2025Feb 3, 2025Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−8K$86.2281−$689.83K205.7K−3.7%SEC10b5-1
Jan 22, 2025Jan 21, 2025GUGGENHIME ANDREWPRESIDENT AND CFOSSaleCommon Stock−8K$86.5107−$692.09K109.49K−6.8%SEC10b5-1
Jan 17, 2025Jan 15, 2025Loxam TeriDirectorSSaleCommon Stock−6.25K$85.1138−$531.96K7.18K−46.6%SEC10b5-1
Jan 7, 2025Jan 6, 2025Eydelman MikhailSVP, GEN COUNSEL & CORP SECSSaleCommon Stock−5K$85.5838−$427.92K28.22K−15.1%SEC10b5-1
Jan 3, 2025Jan 2, 2025Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−8K$83.6601−$669.28K205.7K−3.7%SEC10b5-1
Dec 19, 2024Dec 18, 2024GUGGENHIME ANDREWPRESIDENT AND CFOSSaleCommon Stock−8K$88.7804−$710.24K109.49K−6.8%SEC10b5-1
Dec 10, 2024Dec 9, 2024PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−2.37K$92.2448−$218.25K136.22K−1.7%SEC10b5-1
Dec 9, 2024Dec 5, 2024Eydelman MikhailSVP, GEN COUNSEL & CORP SECSSaleCommon Stock−5K$91.4846−$457.42K28.7K−14.8%SEC10b5-1
Dec 3, 2024Dec 2, 2024PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−15K$92.4529−$1.39M450.3K−3.2%SEC10b5-1
Dec 3, 2024Dec 2, 2024Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−8K$92.4866−$739.89K205.7K−3.7%SEC10b5-1
Nov 19, 2024Nov 18, 2024GUGGENHIME ANDREWPRESIDENT AND CFOSSaleCommon Stock−8K$85.8194−$686.56K109.49K−6.8%SEC10b5-1
Nov 8, 20248:46 PM ETNov 7, 2024PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−2.37K$103.8868−$245.8K137.4K−1.7%SEC10b5-1
Nov 6, 2024Nov 5, 2024Eydelman MikhailSVP, GEN COUNSEL & CORP SECSSaleCommon Stock−5K$106.3635−$531.82K28.62K−14.9%SEC10b5-1
Nov 4, 2024Nov 1, 2024PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−15K$106.817−$1.6M435.22K−3.3%SEC10b5-1
Nov 4, 2024Nov 1, 2024Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−8K$106.8021−$854.42K205.7K−3.7%SEC10b5-1
Oct 22, 2024Oct 18, 2024GUGGENHIME ANDREWPRESIDENT AND CFOSSaleCommon Stock−42K$115.3903−$4.85M90.38K−31.7%SEC10b5-1
Oct 8, 2024Oct 7, 2024PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−7.1K$109.2067−$775.15K138.58K−4.9%SEC10b5-1
Oct 8, 2024Oct 7, 2024Eydelman MikhailSVP, GEN COUNSEL & CORP SECSSaleCommon Stock−5K$109.2733−$546.37K28.62K−14.9%SEC10b5-1
Oct 3, 2024Oct 1, 2024PICKERING GRANTCHIEF EXECUTIVE OFFICERSSaleCommon Stock−55K$114.2509−$6.28M450.22K−10.9%SEC10b5-1
Oct 3, 2024Oct 1, 2024Wassil JimCHIEF OPERATING OFFICERSSaleCommon Stock−8K$114.2441−$913.95K200.65K−3.8%SEC10b5-1
Oct 3, 2024Oct 1, 2024Eydelman MikhailSVP, GEN COUNSEL & CORP SECSSaleCommon Stock−5.5K$114.2353−$628.29K28.62K−16.1%SEC10b5-1
Sep 19, 2024Sep 18, 2024GUGGENHIME ANDREWPRESIDENT AND CFOSSaleCommon Stock−8K$115.9454−$927.56K90.38K−8.1%SEC10b5-1
Sep 18, 2024Sep 17, 2024Loxam TeriDirectorSSaleCommon Stock−6.25K$116.2795−$726.75K7.18K−46.6%SEC10b5-1